Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Pregnancy Complications × relugolix × Clear all

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Prostatic Neoplasms 12 Leiomyoma 4 Prostate Adenocarcinoma 2 Myofibroma 2 Endometriosis 2 Uterine Neoplasms 1 Uterine Hemorrhage 1 Pregnancy Complications 1 Pathologic Complete Response 1 Neoplasm, Residual 1 Myoma 1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 Menorrhagia 1 Adenocarcinoma 1

Interventions

relugolix 1 Observation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05739123 2025-08-19

Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring

Sumitomo Pharma Switzerland GmbH

Endometriosis, Leiomyoma, Pregnancy Complications

Data powered by HemOnc (CC BY 4.0) Colophon ⚡